BACKGROUND: The 2013 cholesterol management guidelines from the American College of Cardiology and American Heart Association (ACC/AHA) recommend lipid screening in all adults older than 20 years to identify those at increased risk for atherosclerotic cardiovascular disease (ASCVD). Statins may be considered for patients with elevated 10-year risk (>5%) or a low-density lipoprotein cholesterol (LDL-C) level of 4.92 mmol/L (190 mg/dL) or greater. OBJECTIVE: To describe the prevalence of elevated ASCVD risk among nondiabetic adults younger than 50 years. DESIGN: Cross-sectional. SETTING: NHANES (National Health and Nutrition Examination Survey), 1999 to 2000 through 2011 to 2012. PARTICIPANTS: Adults aged 30 to 49 years without known ASCVD or diabetes. MEASUREMENTS: 10-year ASCVD risk was estimated by using the 2013 ACC/AHA ASCVD risk calculator. Participants were subdivided by age, sex, and history of smoking and hypertension. The percentages of adults in each subgroup with a 10-year ASCVD risk greater than 5% and of those with an LDL-C level of 4.92 mmol/L (190 mg/dL) or greater were estimated. Low-prevalence subgroups were defined as those in which a greater than 1% prevalence of elevated cardiovascular risk could be ruled out (that is, the upper 95% confidence bound for prevalence was ≤1%). RESULTS: Overall, 9608 NHANES participants representing 67.9 million adults were included, with approximately half (47.12%, representing 32 million adults) in low-prevalence subgroups. In the absence of smoking or hypertension, 0.09% (95% CI, 0.02% to 0.35%) of adult men younger than 40 years and 0.04% (CI, 0.0% to 0.26%) of adult women younger than 50 years had an elevated risk. Among other subgroups, 0% to 75.9% of participants had an increased risk. Overall, 2.9% (CI, 2.3% to 3.5%) had an LDL-C level of 4.92 mmol/L (190 mg/dL) or greater. LIMITATION: No information was available regarding cardiovascular outcomes. CONCLUSION: In the absence of risk factors, the prevalence of increased ASCVD risk is low among women younger than 50 and men younger than 40 years. PRIMARY FUNDING SOURCE: None.
BACKGROUND: The 2013 cholesterol management guidelines from the American College of Cardiology and American Heart Association (ACC/AHA) recommend lipid screening in all adults older than 20 years to identify those at increased risk for atherosclerotic cardiovascular disease (ASCVD). Statins may be considered for patients with elevated 10-year risk (>5%) or a low-density lipoprotein cholesterol (LDL-C) level of 4.92 mmol/L (190 mg/dL) or greater. OBJECTIVE: To describe the prevalence of elevated ASCVD risk among nondiabetic adults younger than 50 years. DESIGN: Cross-sectional. SETTING: NHANES (National Health and Nutrition Examination Survey), 1999 to 2000 through 2011 to 2012. PARTICIPANTS: Adults aged 30 to 49 years without known ASCVD or diabetes. MEASUREMENTS: 10-year ASCVD risk was estimated by using the 2013 ACC/AHA ASCVD risk calculator. Participants were subdivided by age, sex, and history of smoking and hypertension. The percentages of adults in each subgroup with a 10-year ASCVD risk greater than 5% and of those with an LDL-C level of 4.92 mmol/L (190 mg/dL) or greater were estimated. Low-prevalence subgroups were defined as those in which a greater than 1% prevalence of elevated cardiovascular risk could be ruled out (that is, the upper 95% confidence bound for prevalence was ≤1%). RESULTS: Overall, 9608 NHANES participants representing 67.9 million adults were included, with approximately half (47.12%, representing 32 million adults) in low-prevalence subgroups. In the absence of smoking or hypertension, 0.09% (95% CI, 0.02% to 0.35%) of adult men younger than 40 years and 0.04% (CI, 0.0% to 0.26%) of adult women younger than 50 years had an elevated risk. Among other subgroups, 0% to 75.9% of participants had an increased risk. Overall, 2.9% (CI, 2.3% to 3.5%) had an LDL-C level of 4.92 mmol/L (190 mg/dL) or greater. LIMITATION: No information was available regarding cardiovascular outcomes. CONCLUSION: In the absence of risk factors, the prevalence of increased ASCVD risk is low among women younger than 50 and men younger than 40 years. PRIMARY FUNDING SOURCE: None.
Authors: Samuel S Gidding; Mary Ann Champagne; Sarah D de Ferranti; Joep Defesche; Matthew K Ito; Joshua W Knowles; Brian McCrindle; Frederick Raal; Daniel Rader; Raul D Santos; Maria Lopes-Virella; Gerald F Watts; Anthony S Wierzbicki Journal: Circulation Date: 2015-10-28 Impact factor: 29.690
Authors: Amit V Khera; Hong-Hee Won; Gina M Peloso; Kim S Lawson; Traci M Bartz; Xuan Deng; Elisabeth M van Leeuwen; Pradeep Natarajan; Connor A Emdin; Alexander G Bick; Alanna C Morrison; Jennifer A Brody; Namrata Gupta; Akihiro Nomura; Thorsten Kessler; Stefano Duga; Joshua C Bis; Cornelia M van Duijn; L Adrienne Cupples; Bruce Psaty; Daniel J Rader; John Danesh; Heribert Schunkert; Ruth McPherson; Martin Farrall; Hugh Watkins; Eric Lander; James G Wilson; Adolfo Correa; Eric Boerwinkle; Piera Angelica Merlini; Diego Ardissino; Danish Saleheen; Stacey Gabriel; Sekar Kathiresan Journal: J Am Coll Cardiol Date: 2016-04-03 Impact factor: 24.094
Authors: Roger Chou; Tracy Dana; Ian Blazina; Monica Daeges; Christina Bougatsos; Thomas L Jeanne Journal: Ann Intern Med Date: 2016-08-09 Impact factor: 25.391
Authors: C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins Journal: Lancet Date: 2010-11-08 Impact factor: 79.321
Authors: Andrew Paul DeFilippis; Rebekah Young; John W McEvoy; Erin D Michos; Veit Sandfort; Richard A Kronmal; Robyn L McClelland; Michael J Blaha Journal: Eur Heart J Date: 2017-02-21 Impact factor: 29.983
Authors: Jorie Versmissen; Daniëlla M Oosterveer; Mojgan Yazdanpanah; Joep C Defesche; Dick C G Basart; Anho H Liem; Jan Heeringa; Jacqueline C Witteman; Peter J Lansberg; John J P Kastelein; Eric J G Sijbrands Journal: BMJ Date: 2008-11-11
Authors: Avinainder Singh; Bradley L Collins; Ankur Gupta; Amber Fatima; Arman Qamar; David Biery; Julio Baez; Mary Cawley; Josh Klein; Jon Hainer; Jorge Plutzky; Christopher P Cannon; Khurram Nasir; Marcelo F Di Carli; Deepak L Bhatt; Ron Blankstein Journal: J Am Coll Cardiol Date: 2017-11-12 Impact factor: 24.094
Authors: Joseph A Ladapo; John M Pfeifer; James M Pitcavage; Brent A Williams; Alana A Choy-Shan Journal: J Womens Health (Larchmt) Date: 2018-12-13 Impact factor: 2.681
Authors: Yiyi Zhang; Eric Vittinghoff; Mark J Pletcher; Norrina B Allen; Adina Zeki Al Hazzouri; Kristine Yaffe; Pallavi P Balte; Alvaro Alonso; Anne B Newman; Diane G Ives; Jamal S Rana; Donald Lloyd-Jones; Ramachandran S Vasan; Kirsten Bibbins-Domingo; Holly C Gooding; Sarah D de Ferranti; Elizabeth C Oelsner; Andrew E Moran Journal: J Am Coll Cardiol Date: 2019-07-23 Impact factor: 24.094
Authors: Agnish Nayak; Andrew Hayen; Lin Zhu; Kevin McGeechan; Paul Glasziou; Les Irwig; Jenny Doust; Gabriel Gregory; Katy Bell Journal: BMJ Open Date: 2018-10-04 Impact factor: 2.692